ARQ Genetics

ARQ Genetics

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.5M

Overview

ARQ Genetics is a specialized contract research organization (CRO) providing custom qPCR and gene expression services to the research community. Founded in 2018 and based in Bastrop, Texas, the company differentiates itself through a flexible, client-driven approach with no minimum order requirements and a staff composed entirely of Ph.D. scientists. Its business model is built on offering researchers a cost-effective alternative to establishing in-house qPCR capabilities, with a strong track record evidenced by client publications in peer-reviewed journals. The company appears to be a privately-held, revenue-generating services business.

Genetics & Genomics

Technology Platform

Service platform for custom qPCR/RT-PCR gene expression analysis, leveraging Ph.D.-level scientific expertise, custom assay design, and a full workflow from RNA isolation to data delivery.

Funding History

1
Total raised:$2.5M
Seed$2.5M

Opportunities

Growing demand for outsourced, specialized molecular biology services from academic and small biotech researchers.
Potential to expand tailored service offerings in high-need verticals like veterinary oncology diagnostics.
The trend towards research outsourcing provides a favorable market tailwind.

Risk Factors

Intense competition from other CROs and academic core facilities could pressure pricing.
Revenue is project-based and susceptible to fluctuations in client research funding.
Longer-term risk of technological displacement by next-generation sequencing for some gene expression applications.

Competitive Landscape

ARQ Genetics competes in the qPCR services market against large, diversified CROs (e.g., LabCorp, Charles River), university core facilities, and other niche service providers. Its key differentiators are its fully Ph.D. staff, extreme customization flexibility with no minimum orders, and a focus on publication-quality data for targeted gene expression studies.